- Argentina
- Australia
- Austria
- Bangladesh
- Belgium
- Botswana
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Cuba
- Czech Republic
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Latvia
- Lebanon
- Lithuania
- Malaysia
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Senegal
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Vietnam
- Zimbabwe
China Health News API
Get the live top health headlines from China with our JSON API.
Get API key for the China Health News APIAPI Demonstration
This example demonstrates the HTTP request to make and the JSON response you will receive when you use the news api to get the top headlines from China.
GET
https://gnews.io/api/v4/top-headlines?country=cn&category=health&apikey=API_KEY
{
"totalArticles": 4393,
"articles": [
{
"id": "9105da2a3f711f85ec6d7f12e77d6b11",
"title": "抗抑郁药物的副作用可怕吗?",
"description": "《刺胳针》(The Lancet)发布一项涵盖5.8万人的大型研究,针对30种抗抑郁药的体重、血压与心跳等副作用进行全面排名。该研究量化了常见药物的代谢影响,有助患者与医师在疗效与风险间,做出更适合个人的用药选择。",
"content": "抑郁症,又称忧郁症,是一种精神类疾病,主要表现为长期情绪低落、对事物失去兴趣,并伴随精力下降、睡眠和食欲改变、注意力不集中等,严重时会产生自残或自杀想法。 研究认为,这与当今社会型态给人带来的各种压力有直接关系,虽然其表现涉及遗传、生理、心理及环境等单一和交叉因素。为此,现代医学研制出了多种抗抑郁药,对改善患者的状态,甚至恢复正常生活起到了很好的作用。\n以英国为主的20多个医学专家,针对多种抗忧郁药(含未上市的)进行了一次大型研究,涉及5.8万人,以分析这些药物给患者带来的副作用,包括体重、血压... [2885 chars]",
"url": "https://www.epochtimes.com/gb/26/1/5/n14669778.htm",
"image": "https://i.epochtimes.com/assets/uploads/2026/01/id14669807-Screenshot-2026-01-05-700x359.jpg",
"publishedAt": "2026-01-08T23:00:00Z",
"lang": "zh",
"source": {
"id": "c6c58860d5157a4328fed63d53d6ed93",
"name": "大紀元新聞網",
"url": "https://www.epochtimes.com"
}
},
{
"id": "9a51b860736a7503786d98160b8c0cdf",
"title": "重组IHNV糖蛋白疫苗对虹鳟(Oncorhynchus mykiss)肠道黏膜免疫和微生物群结构的影响",
"description": "彩虹鳟鱼IHN疫苗开发及肠道免疫与菌群调控研究",
"content": "摘要\n传染性造血坏死(IHN)对虹鳟水产养殖业构成了重大威胁,而疫苗接种是预防和控制该疾病的有效策略。为了阐明重组IHNV-G蛋白疫苗在虹鳟中的免疫保护效果及其对肠道黏膜免疫和微生物群组成的调节作用,本研究开发了该疫苗,并以虹鳟为模式生物进行了实验评估。在接种疫苗30天后,将鱼暴露于5.25 × 10? PFU的IHNV病毒中。首先通过挑战实验评估了疫苗的免疫保护效果。随后,通过结合肠道组织的组织病理学检查、血清抗体的检测、肠道免疫相关基因表达的分析以及肠道微生物群的16S rDNA测序,系统地... [1042 chars]",
"url": "https://www.ebiotrade.com/newsf/2026-1/20260108233546162.htm",
"image": "https://www.ebiotrade.com/ColorQR_ebiotrade.jpg",
"publishedAt": "2026-01-08T16:27:37Z",
"lang": "zh",
"source": {
"id": "2b5d4423af22e4969a71a078ec67ad04",
"name": "生物通",
"url": "https://www.ebiotrade.com"
}
},
{
"id": "468fd30bf314150d9fc3e50b714cb5fb",
"title": "匈牙利甲型肝炎感染病例数量急剧上升",
"description": "匈牙利甲型肝炎感染病例数量急剧上升",
"content": "(匈牙利联合报/多瑙视野)根据国家公共卫生和药学中心(NNGYK)的数据,2025年匈牙利甲型肝炎感染病例数量急剧上升:截至当年第52周,共有2048例病例,是上年同期病例数的7倍,是2023年的11倍。\n根据国家公共卫生研究所周一公布的数据,疫情在不同地区的发展情况不尽相同:首都的传播速度有所放缓,而博尔绍德-奥包伊-曾普伦州和索博尔奇-索特马尔-贝雷格州的病毒传播速度则有所加快。\n2025 年第 52 周新增 15 例甲型肝炎感染病例,使病例总数达到 2048 例。这是一个异常高的值:是 2... [575 chars]",
"url": "http://www.lianhenews.com/static/content/XYLXW/2026-01-08/1458955842296512512.html",
"image": "http://www.lianhenews.com/resource/common/images/favicon.ico",
"publishedAt": "2026-01-08T14:50:47Z",
"lang": "zh",
"source": {
"id": "22c1d9f643446c7976247dcfe73c2d1b",
"name": "lianhenews.com",
"url": "http://www.lianhenews.com"
}
}
]
}